Journal of the Association of Nurses in AIDS Care
Volume 22, Issue 1 , Pages 17-25 , January 2011

Aging With HIV: A Cross-Sectional Study of Comorbidity Prevalence and Clinical Characteristics Across Decades of Life

References 

  1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–299
  2. Bisson G, Gross R, Miller V, Weller I, Walker A, Arlett P, et al Monitoring of long-term toxicities of HIV treatments: An international perspective. AIDS. 2003;17:2407–2417
  3. Casau NC. Perspective on HIV infection and aging: Emerging research on the horizon. Clinical Infectious Diseases. 2005;41:855–863
  4. Cellerai C, Little SJ, Loes SK. Treatment of acute HIV-1 infection: Are we getting there?. Current Opinion in HIV and AIDS. 2008;3:67–74
  5. Centers for Disease Control and Prevention . HIV/AIDS among persons aged 50 and older: CDC HIV/AIDS facts. Washington, DC: U.S. Department of Health and Human Services; 2008;Retrieved from http://www.cdc.gov/hiv/topics/over50/index.htm
  6. Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, et al Distribution of health care expenditures for HIV-infected patients. Clinical Infectious Diseases. 2006;42:1003–1010
  7. Collazos J, Asensi V, Carton JA, Ibarra S. The influence of the patients' educational levels of socioeconomic, clinical, immunological and virological endpoints. AIDS Care. 2009;6:1–9
  8. Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al Workshop on HIV infection and aging: What is known and future research directions. Clinical Infectious Diseases. 2008;47:542–553
  9. Friis-Møller M, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients—association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179–1193
  10. Giordano TP, White AC, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, et al Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. Journal of Acquired Immune Deficiency Syndrome. 2003;32:399–405
  11. Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, et al Do patterns of comorbidity vary by HIV status, age, and HIV severity?. Clinical Infectious Diseases. 2007;45:1593–1601
  12. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. Journal of Gerontology: Biological Science and Medical Science. 2006;61:511–515
  13. Henry, J. Kaiser Family Foundation. (2007). HIV/AIDS policy fact sheet, July 2007. Retrieved from http://www.kff.org/hivaids/upload/3029-071.pdf
  14. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS. 2004;17:S19–S26
  15. Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, et al Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS. 2004;18:S49–S60
  16. Kirk JB, Goetz MB. Human immunodeficiency virus in an aging population, a complication of success. Journal of the American Geriatric Society. 2009;57:2129–2138
  17. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic). Acquired Immune Deficiency Syndrome. 2008;48:590–598
  18. Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnett F, et al Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS. International Journal of Epidemiology. 2005;34:121–130
  19. Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21:685–692
  20. Perez JL, Moore RD. Greater effect of Highly Active Antiretroviral Therapy on survival in people aged ≥50 years compared with younger people in an urban observational cohort. Clinical Infectious Diseases. 2003;36:212–218
  21. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. British Journal of Clinical Pharmacology. 2004;57:121–126
  22. Shippy RA, Karpiak SE. The aging HIV/AIDS population: Fragile social networks. Aging and Mental Health. 2005;9:246–254
  23. Vance DE, Burrage JW, Couch A, Raper JL. Promoting successful aging with HIV through hardiness: Implications for nursing research and practice. Journal of Gerontological Nursing. 2008;343:22–31
  24. Vance DE, Childs G, Moneyham L, McKie-Bell P. Barriers to successful aging with HIV: A brief overview for nursing. Journal of Gerontological Nursing. 2009;24:19–25
  25. Welch K, Morse A. Predictors of survival in older men with AIDS. Geriatric Nursing. 2002;23:62–75

PII: S1055-3290(10)00064-6

doi: 10.1016/j.jana.2010.04.002

Journal of the Association of Nurses in AIDS Care
Volume 22, Issue 1 , Pages 17-25 , January 2011

Article Tools

* Image Usage & Resolution